United States · Markets & Finance · Morningstar

Celaid Therapeutics Completes Second Close of Series B Financing Round

Published by Morningstar · United States 8 h ago

TOKYO, Oct. 4, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO: Nobuyuki Arakawa; "Celaid") today announced the completion…

Read the full article on Morningstar Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.morningstar.com)

Also worth reading

Cointelegraph

Zcash gets a Washington lobbyist to push crypto policy

Fortune

Air Force removes all bombers from British base and redeploys them to the U.S. after a planned terror attack linked to Iran was foiled

OilPrice.com

Fuel Price Shock Pushes Global Gas Car Sales Below 50% for First Time

Seeking Alpha

U.K. is said to plan tariffs on Chinese EVs under pressure from EU

CNBC

Supreme Court Justice Alito said he's 'thought about' retirement as Senate control hangs in balance

NYT Business